Antiphospholipid Syndrome: Not All Antibodies Are Created Equal
Nicola Pozzi, Associate Professor of Thrombosis and Hemostasis and Autoimmunity at Saint Louis University School of Medicine, shared a post on LinkedIn:
”Antiphospholipid Syndrome (APS) isn’t a one-size-fits-all disease—and neither are antiphospholipid antibodies.
In our latest work, led by Suresh Kumar, we advance understanding of the molecular complexity behind pathogenic antibodies targeting β2GPI and, in doing so, we introduce new concepts and tools that may help achieve more personalized diagnostic strategies and accelerate the development of neutralization approaches.
Our goal of building an Antiphospholipid Antibody Atlas to fight APS continues… Just keep watching APS…Just keep watching…”
For more information
Find More Posts on Hemostasis Today.
-
Apr 23, 2026, 04:08Suraj Mali: Pune Team Initiative for World Hemophilia Day 2026 Advances Early Diagnosis in Hemophilia
-
Apr 23, 2026, 03:58Adam Ho: What Does It Actually Mean to ”Prevent” a Stroke?
-
Apr 23, 2026, 03:49Jakob Krebs Christensen: Mobile Stroke Units Bring Imaging and Treatment Directly to the Patient
-
Apr 23, 2026, 03:30Kimberly Waddell: Mismatch in Post-Stroke Discharge Decisions Impacts Long-Term Recovery
-
Apr 23, 2026, 03:18Pablo Corral: Key Take‑Home Messages on Familial Hypercholesterolemia
-
Apr 23, 2026, 03:17Wolfgang Miesbach: The Haemophilia A Gene Therapy Story Is Moving from West to China
-
Apr 23, 2026, 02:17Francisco Chacón-Lozsán: Pulmonary Artery Catheter in Cardiogenic Shock From Obsolete Device to Modern Decision Tool
-
Apr 23, 2026, 01:33Maha Othman: Our Research Group Had a Highly Successful Showing at the ISLH 2026 Congress
-
Apr 22, 2026, 17:19Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases